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ABSTRACT 
  
Health-Related Quality of Life (HRQOL) is the leading construct for measuring 
the impact of chronic illness on general well-being in pediatric populations. Little is 
known about what factors contribute to HRQOL in pediatric cystic fibrosis (CF). The 
current study hypothesized that family functioning and treatment burden would impact 
HRQOL and explored treatment burden as a potential moderator using self and parent-
proxy reports. 
Self-report results confirmed that “unhealthy” family functioning (F(4,43) = 
3.83, p = 0.01, R2 = 0.26, R2adjusted = 0.20) predicted poor HRQOL, controlling for age 
and disease severity. Greater treatment burden perceptions were also associated with 
poor HRQOL using a self-report score (F(4,43) = 4.14 , p = 0.01, R2 = 0.28, R2adjusted = 
0.21) and the CFQ-R treatment burden subscale (F(4,45) = 3.29, p = 0.01, R2 = 0.29, 
R2adjusted = 0.20), controlling for age and disease severity. Parent-proxy report results 
demonstrated significant relationships for family functioning (α = -0.34, p < 0.05) and 
treatment burden (α = 0.46, p < 0.05) with HRQOL as well. Moderation analyses 
indicated that the relationship between family functioning and HRQOL was not 
dependent upon treatment burden perceptions in either child or parent-proxy report. 
However, the overall models suggested that together age, disease severity, family 
functioning, and treatment burden accounted for significant variance in HRQOL scores 
for self-report (R2 = 0.32, F(5,47) = 4.03, p = 0.004) and parent-proxy report (R2 = 0.25, 
F(2,23) = 3.90, p = 0.035). 
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 Results confirm previous findings that family functioning is related to HRQOL 
in pediatric CF. This is the first study to suggest that perceptions of treatment burden are 
related to HRQOL. Overall findings suggest that children who experience “unhealthy” 
family functioning and greater treatment burden perceptions are at risk for experiencing 
diminished HRQOL. Intervention efforts to promote familial support and monitoring 
perceptions of treatment burden may be useful in promoting greater HRQOL within 
pediatric CF.   
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INTRODUCTION 
 
Cystic Fibrosis (CF) is the second most common genetic disorder in children, 
occurring in 1 in every 3,700 births (Centers for Disease Control and Prevention, 2004). 
With approximately 1,000 new cases of CF each year, there are an estimated 30,000 
children and adults living with CF in the United States alone (Cystic Fibrosis 
Foundation, 2014).  Despite increases in life expectancy over the past decade (Cystic 
Fibrosis Foundation, 2014), CF remains a chronic, progressive, and fatal disease with 
lung infections being the most common cause of morbidity (Morgan et al., 1999). 
Cystic Fibrosis is determined by the inheritance of specific genes from each 
parent. The impact of the disease is most profuse throughout the respiratory and 
digestive systems, however, the disease impacts all systems of the body. CF symptoms 
such as coughing, mucus production, wheezing, shortness of breath, and lung infections 
occur as a result of mucus blockage in the respiratory system (Cunningham & Taussig, 
2003; National Heart, Lung, and Blood Institute, 2013). Further, thick mucus in the 
pancreas blocks digestive enzymes, and ultimately the absorption of nutrients, resulting 
in poor weight gain, greasy stools, stomachaches, and excessive gas (Cunningham & 
Taussig, 2003; National Heart, Lung, and Blood Institute, 2013). The severity and 
profuseness of these symptoms is determined by the individual’s inheritance of specific 
variations of the genes related to CF.  
The breadth of symptoms associated with CF has resulted in a need for diverse 
and extensive treatment strategies. Typically, regimens include several respiratory 
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interventions aimed at thinning mucus, clearing airways, and treating infections in 
combination with digestive interventions to address malabsorption such as a high fat, 
high calorie diets, pancreatic enzyme replacements, and high doses of vitamins 
(Cunningham & Taussig, 2003).  Treatment regimens for most individuals with CF have 
been found to be extremely time-consuming, complex, and costly, often more so than 
other pediatric chronic illnesses (Herzer et al., 2010). Further, these treatments are only 
useful at prolonging vitality by preserving lung functioning and sustaining nutrition, but 
there is not a cure for CF.  
Research in adults suggests that at some point, the number of therapies and 
resulting perceptions of treatment burden may outweigh the benefits of adhering to the 
therapy regimen (Sawicki, Sellers, & Robinson, 2009). Thus, it has become increasingly 
important to determine how the burden of CF treatments not only impacts objective 
clinical measures, but also how it impacts an individual’s general well-being, or health-
related quality of life (HRQOL). Given that in pediatric populations the demands of CF 
are a shared responsibility and stressor between the child and their family, further 
examination of how treatment burden impacts the overall family system is critical to 
encourage continued management and administration of the complex treatment regimen.  
Health-Related Quality of Life in Pediatric Cystic Fibrosis  
 Given the aggressive and time-consuming treatments that are necessary for 
prolonged life expectancy in CF and other pediatric chronic illnesses, objective outcome 
measures such as survival rates are no longer considered sufficient for capturing how the 
child fares (Eiser, Mohay, & Morse, 2000). Recommended meaningful outcome 
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measures should include the patients’ subjective assessment of how their medical 
demands (i.e. cost of treatment, time dedicated to treatment, pain involved in treatment) 
impact their psychosocial functioning (Upton, Lawford, & Eiser, 2008; Schor, 2007; 
Britto, Kotagal, Chenier, Tsevat, Atherton, & Wilmott, 2004). Within the past decade, 
health-related quality of life (HRQOL) has emerged as a leading construct for measuring 
the impact of various aspects of chronic illness on a child’s overall functioning, 
including pediatric CF. In fact, The Cystic Fibrosis Foundation and the National Heart, 
Lung and Blood Institute have recommended using HRQOL as a standard measure in 
clinical trials and practice with pediatric CF patients (Abbott, 2011; Arrington-Sanders, 
2006; Goldbeck, Zerrer, & Schmitz, 2007; Eigen, Clark, & Wolle,1987).  
A vast body of literature suggests that defining HRQOL is multi-faceted. First, 
HRQOL is a subjective assessment, or patient-reported outcome of one’s own perception 
of the impact that an illness or medical treatment has had on their psychosocial 
functioning (e.g. Varni & Limbers, 2009; Spieth, & Harris, 1996). Second, HRQOL is 
multidimensional, meaning that the construct spans the measurement of functioning 
across several domains (e.g. Eiser & Morse, 2001; Eiser, 1997; Spieth, & Harris, 1996). 
This is largely based on the original definition by the World Health Organization, which 
delineated health into three dimensions including physical, mental, and social health 
(Eiser, Mohay, & Morse, 2000; Speith & Harris, 1996; World Health Organization, 
1948). As a result, HRQOL typically assesses physical, psychological, and social 
functioning (Matza, Swensen, Flood, Secnik, & Leidy, 2004; Eiser et al., 2000; Speith, 
1996). There is less agreement on the specific domains that are measured within these 
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three broader categories (Speith & Harris, 1996), depending on age (Matza et al., 2004), 
and disease-specific areas of concern (Speith & Harris, 1996). For example, some 
measures of HRQOL may include school functioning, neuropsychological functioning, 
appearance satisfaction, etc. (Speith & Harris, 1996), depending on relevance to the 
population they are used to assess.  
 Two important considerations are necessary when utilizing HRQOL 
measurements in pediatric chronic health populations. First, it has been well-documented 
that significant differences exist in parent-proxy and child self-report ratings of HRQOL 
(e.g. Ingerski et al., 2010; Upton, Lawford, & Eiser, 2008; Varni, Katz, Colegrove,& 
Dolgin, 1996), although the different studies seem to report various discrepancies and 
similarities within specific HRQOL domains. In a large meta-analysis, it was determined 
that there is low agreement in parent-proxy and child self-report on the domains of 
emotional and social HRQOL, while ratings in the domains of general functioning and 
physical functioning were in greater agreement across pediatric chronic illness 
populations (Eiser & Morse, 2001).   
In pediatric CF, there is limited research devoted to examining these 
discrepancies. One study suggests that adolescents with CF rate their overall HRQOL as 
better than their parents, and consistent with literature on other pediatric chronic health 
populations, the largest discrepancies occurred in the domains of worry about health and 
susceptibility to disease (Britto, Kotagal, Chenier, Tsevat, Atherton, & Wilmott, 2004). 
However, that same study found that adolescents with CF and their parents reported 
similar levels of overall mental health and pain, which tend to be less similar in other 
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pediatric chronic health populations due to the internal nature of these domains (Britto et 
al., 2004). Thus, further research is needed to examine how parent-proxy and child self-
report differs for HRQOL in pediatric CF.  
It is important to maintain awareness of the differences in parent-proxy and child 
self-report; however, research suggests that there may be circumstances in which parent 
proxy-report is useful such as when a child is too young, ill, or too impaired to provide 
self-report (Varni & Limbers, 2009). Further, it has been suggested that parents’ 
perceptions of the chronically ill child’s HRQOL are more likely to influence health care 
decisions, such as adherence to medical treatment (Varni & Limbers, 2009; Campo, 
Comer, Jansen-McWilliams, Gardner & Kelleher, 2002; Janicke, Finney & Rile, 2001). 
As a result, the current standard is to acquire reports from multiple informants (both 
parent-proxy and child self-report) when possible. 
 The second consideration with regard to the measurement of HRQOL is the 
difference between generic and disease-specific measures. Generic HRQOL measures 
are used in both ill and healthy populations allowing for comparisons and contain 
subscales that are applicable across individuals in both groups (Varni & Limbers, 2009). 
In contrast, disease-specific measures capture the impact of a specific illness or disease 
on the individual’s functioning (Varni & Limbers, 2009; Solans et al., 2008). For 
example, disease-specific measures for pediatric CF include questions that address how 
respiratory and digestive symptoms impact functioning across domains. Since each 
approach serves a unique purpose, it is suggested that both generic and disease-specific 
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HRQOL measures be administered to acquire a comprehensive evaluation (Varni & 
Limbers, 2009).  
 Research on how children and parents rate HRQOL in pediatric CF is less 
extensive than other pediatric chronic illnesses (e.g. pediatric cancer) with many studies 
combining adolescent and adult populations and taking place outside of the United 
States. This research does suggest that the majority of children with CF fair within one 
standard deviation of their healthy peers. As a result, studies continue to investigate what 
factors contribute to the subset of individuals who demonstrate poor adjustment (Wong 
& Heriot, 2008). Within this context, studies have examined the relationship between 
biological markers of cystic fibrosis disease severity and HRQOL, resulting in mixed 
findings (Powers, Gerstle & Lapey, 200; de Jong et al., 1997; Jedlicka-Köhler, & Götz, 
1988).  Even those studies that do suggest a significant relationship note that disease 
severity accounts for only a small portion of the variance in HRQOL ratings, 
highlighting the idea that there are additional factors contributing to poor adjustment 
(Drotar, Doershuk, Stern, Boat, Boyer & Matthews, 1981;Wong & Heriot, 2008). 
Gender has also been linked to variations in HRQOL reports, such that adolescent 
females with CF report lower HRQOL in all domains except role behavior compared to 
their male counterparts (Arrington-Sanders, Yi, Tsevat, Wilmott, Mrus, & Britto, 2006). 
Given the limited findings regarding what contributes to poor HRQOL in pediatric CF, 
researchers have suggested that family functioning may be a potential factor in 
predicting childhood adjustment (Hegarty, MacDonald, Watter, & Wilson, 2008; 
Schmitz & Goldbeck, 2006; Patterson, McCubbin & Warwick, 1990) given that this link 
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has been present in other pediatric chronic health populations such as diabetes (e.g. 
Grey, Boland, Yu, Sullivan-Bolyai, & Tamborlane, 1998). 
Family Functioning in Pediatric Cystic Fibrosis 
 It is well documented that having a chronic medical condition can be a familial 
stressor resulting in distress for all individuals, disruptions of family roles and structure, 
and diminished family cohesion (Herzer et al., 2010; Quittner et al., 2000; Drotar, 1997). 
There are mixed results regarding whether families of children with pediatric chronic 
illness are more likely to function in “unhealthy” ranges compared to families with 
healthy children; however it has been suggested that there are a least a subset that do 
demonstrate “unhealthy” general family functioning, poor division of responsibility for 
completing tasks, and poor communication (Herzer et al., 2010).  
As in other pediatric chronic health populations, families of children with CF can 
experience distress related to the demanding, progressive, and fatal nature of the disease 
(Herzer et al., 2010; DeLambo, Ievers-Landis, Drotar, & Quittner, 2004; Patterson et al., 
1990). In fact, families of children with CF may experience greater distress and more 
time spent on treatment-related activities than families of children with asthma, often at 
the cost of family recreational activities (Modi & Quittner, 2006).  
The majority of studies on family functioning in CF are observational assessment 
studies of mealtime in preschool and young children. In contrast to the emotional and 
interactional experience that mealtime is for healthy families, it is often a stressful event 
in which parents of children with CF must focus on the treatment goal of ensuring 
sufficient caloric intake for their child (Stark et al., 2000). As a result, parents are 
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required to be more task-oriented and abandon typical parenting techniques, leading to 
lower overall family communication, affect management, interpersonal involvement, 
behavioral control, and role allocation (Spieth, Stark, & Mitchell, 2001; Janicke, 
Mitchell, & Stark, 2005; Crist et al., 1994).  
 While mealtime studies suggest that family functioning may improve with age 
alternative family characteristics in pediatric CF may cause disruption during 
adolescence. Parents of children with CF have been found to be over-protective and 
engage in extreme levels of parental monitoring (Patterson et al., 1990). In fact, as many 
as 77% of parents of children with CF admit to over-protecting their child (Phillips, 
Bohannon, Gayton, & Friedman, 1985). While this is advantageous for ensuring 
treatment compliance, it hinders normative adolescent development (especially the 
increasing need for autonomy) and can result in subsequent behavior problems 
(Szyndler, Towns, Asperen, & McKay, 2005; Drotar & Ievers, 1994; Cappelli et al., 
1988).  
 More general factors have also been linked to how parents adjust to having a 
child with CF. Poor parental adjustment has been associated with high levels of daily 
stress regarding illness tasks and poor family involvement. Positive adjustment has been 
linked to paternal involvement with the family, maternal involvement outside of the 
family, family communication, and time for recreation (Kulczycki, Robinson, & Berg, 
1969; Patterson, 1990). These factors are important given that parents’ overall 
adjustment to the disease has an impact on the well-being of the child with CF.  
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 One difficulty that has plagued the understanding of how families of children 
with chronic illnesses function, including those with CF, is a lack of a cohesive 
theoretical approach for conceptualizing their functioning (Alderfer, 2008). For example, 
in CF, theories such as the Transactional Stress and Coping Model (e.g., Thompson, 
Gustafson, Hamlett, & Spock, 1992), the Family Adjustment and Adaptation Response 
Model (e.g., Patterson et al., 1990), and the McMaster Model of Family Functioning 
(e.g., Herzer, 2010) have all been used to understand the impact of the disease on various 
areas of functioning. To complicate matters more, studies constantly use different 
assessment measures to operationalize family functioning, many of which call 
overlapping dimensions by differing terms and use different dimensions to summarize 
“general” family functioning (Herzer, 2010; Drotar, 1997). Also, some measures 
specifically capture the impact of the chronic illness on the family while others are more 
general; only the later allow for comparisons between families with healthy children and 
those with a child with pediatric chronic illness. Given the slew of theoretical 
explanations and assessment tools, it is difficult to summarize the specific impact that 
CF has on family functioning. 
Impact of Family Functioning on HRQOL 
 Research does suggest that changes in family functioning impact the child with 
the disease. Relationship characteristics such as family cohesion, conflict, organization, 
expressiveness, and adaptability have all been related to HRQOL in children and 
adolescents with CF (Szyndler, Towns, Asperen, & McKay, 2005; Cappelli et al., 1988). 
Children that demonstrate poor levels of HRQOL tend to be from families that function 
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at the extreme levels (high or low) of family characteristics. For example, lack of 
familial involvement or over-involvement can both detrimental to the well-being of the 
child and result in behavior problems at home and school (Szyndler, Towns, Asperen, & 
McKay, 2005; Drotar & Ievers, 1994; Cappelli et al., 1988).  Familial variables have 
also been used to predict the HRQOL domain of self-esteem (Cappelli et al., 1988).  
However, many of these studies took place using outdated measures of HRQOL. 
Consistent research on the impact of family functioning on HRQOL in children with CF 
appears to be absent.  
 Family Functioning, HRQOL and Treatment Burden 
 Preliminary studies suggest that families who experience disruptions in 
functioning as a result of their child’s CF may differ on one important characteristic: 
their perceptions of the stress and burden associated with the disease. It is well 
documented that both parents and children perceive the treatment regimen for CF as 
burdensome and stressful (e.g. Jamieson, Fitzgerald, Singh-Grewal, Hanson, Craig, & 
Tong, 2014). Furthermore, as demonstrated in mealtime studies which are thought to 
represent illness burden (Janicke et al., 2005), the majority of parents report having at 
least minor difficulties getting their child to comply with treatment requirements and are 
forced to alter their functioning characteristics (Janicke et al., 2005; Spieth et al., 2001; 
Phillips et al., 1985,). Families of children with CF report that they must sacrifice family 
leisure activities in order to allocate sufficient time to completing treatments and caring 
for their child (Quittner, Opipari, Regoli, Jacobsen, & Eigen, 1992). Additionally, poor 
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familial adjustment is linked to higher levels of daily stress regarding treatment tasks 
(Thompson et al., 1992).  
 To date, only one study has directly examined the role of treatment burden and 
HRQOL in pediatric CF. Ziaian et al. (2006) found that although treatment burden was 
higher for children with CF than other pediatric chronic health populations, there was no 
significant correlation with HRQOL among Australian families. However, further 
investigation of this relationship is necessary to expand upon these findings. 
Current Study 
 Given that prior research sheds light on the complexity of the relationship 
between HRQOL, family functioning, and treatment burden in pediatric CF, the current 
study seeks to elaborate on the understanding of how these factors are related. With 
regard for the current recommendations for measuring HRQOL in pediatric chronic 
health populations, the study will utilize both a generic and disease-specific measure of 
HRQOL, both of which allow for a child self-report and parent-proxy report. The current 
study will address the following specific aims:   
Study Aim 1 
 To determine whether self-reported family functioning will be related to self-
reported HRQOL 
 Hypothesis 1: Consistent with previous literature, family functioning will be 
significantly related to HRQOL such that children who perceive difficulties in their 
family functioning will report lower HRQOL.  
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Study Aim 2 
 To determine whether parent-proxy report of family functioning will be related to 
parent-proxy report of HRQOL 
 Hypothesis 2: Consistent with previous literature, family functioning will be 
significantly related to HRQOL, such that parents who perceive difficulties in their 
family functioning will report lower HRQOL in their children. 
Study Aim 3 
To determine whether self-reported treatment burden is related to self-reported 
HRQOL  
Hypothesis 3: It is hypothesized that self-reported treatment burden will be 
associated with self-reported HRQOL, such that children who perceive greater treatment 
burden will report lower HRQOL.  
Study Aim 4 
 To determine whether parent-proxy report of treatment burden is related to 
parent-proxy report of HRQOL 
Hypothesis 4: It is hypothesized that parent-proxy report of treatment burden will 
be associated with parent-proxy report of HRQOL, such that parents who perceive 
greater treatment burden will report lower HRQOL in their children. 
Study Aim 5 
To determine whether self-reported treatment burden moderates the relationship 
between self-reported family functioning and self-reported HRQOL  
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Hypothesis: It is hypothesized that treatment burden will moderate the 
relationship between child-reported family functioning and HRQOL. Specifically, the 
relationship between unhealthy family functioning and poor HRQOL will be stronger 
when children perceive their treatment burden to be greater.   
Study Aim 6 
 To determine whether parent-proxy reports of treatment burden moderate the 
relationship between parent-proxy report of family functioning and parent-proxy report 
of HRQOL. 
Hypothesis 6: It is hypothesized that parent-proxy reports of treatment burden 
will moderate the relationship between parent-proxy report of family functioning and 
HRQOL. Specifically, the relationship between unhealthy family functioning and poor 
HRQOL will be stronger when parents perceive their child’s treatment burden to be 
greater.   
Current Study Exploratory Aims 
 The following analyses were conducted similarly to the specific aims of the 
current study. However, they must be considered exploratory given that there is 
insufficient power to conduct these extensive analyses (Cohen, 1992). Thus, there is an 
increased chance of experiencing Type I and Type II error as a result of running multiple 
analyses on an insufficient sample size (Cohen, 1992).  
Exploratory Aim 1 
 To determine the association between the self-reported subscales of family 
functioning (problem solving, communication, roles, affective responsiveness, affective 
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involvement, behavioral control) and the child self-report domains on the generic 
(physical, emotional, social, and school functioning) and disease-specific (physical 
functioning, vitality, health perceptions, respiratory symptoms, treatment burden, role 
functioning, emotional functioning, social functioning) HRQOL measures 
Exploratory Aim 2 
 To determine the association between the parent-proxy report subscales of family 
functioning (problem solving, communication, roles, affective responsiveness, affective 
involvement, behavioral control) and the parent-proxy report domains on the generic  
(physical, emotional, social, and school functioning) and disease-specific (physical 
functioning, vitality, health perceptions, respiratory symptoms, treatment burden, role 
functioning, emotional functioning, social functioning) HRQOL measures 
Exploratory Aim 3 
 To determine the association between child-reported treatment burden and the 
child self-report domains (physical, psychosocial) on the HRQOL measure.  
Exploratory Aim 4  
 To determine the association between treatment burden and the parent-proxy 
report domains (physical, psychosocial) on the HRQOL measure.  
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METHOD 
 
Participants 
 Participants for the current study were recruited from the Cystic Fibrosis Clinic 
at Children’s Health Children’s Medical Center in Dallas, Texas. 50 children ages 6-18 
and their parents were approached during their scheduled appointment times and asked if 
they were willing to participate in a research study. In accordance with the University of 
Texas Southwestern Institutional Review Board standards, all participants were 
informed of their rights as participants were required to provide written consent/assent, 
and agreed to the release of their medical information in accordance with the Health 
Insurance Portability and Accountability Act.  
Measures 
Health-Related Quality of Life 
 Cystic Fibrosis Questionnaire- Revised (CFQ-R; Quittner, Buu, Messer, Modi, & 
Watrous, 2005). The CFQ-R is a disease-specific measure of HRQOL. The current study 
utilized 4 versions of the measure: CFQ-R Child Report Interview Format for ages 6 to 
11, CFQ-R Child Self-Report Format for ages 12 and 13, CFQ-R Adolescent and Adult 
Self-Report Format for ages 14 and older, and the CFQ-R Parents/Caregiver Proxy 
Report format for parents of children under 13 years of age. There is no parent report 
CFQ-R for children over the age of 13, thus parent report was not collected for older 
participants. 
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 The CFQ-R child interview and self-report measures as well as the parent-proxy 
report consist of 8 subscales: physical, emotional, social, body image, eating, treatment 
burden, respiratory, and digestion. Internal consistency on the CFRQ-R child version 
range from .60 to .76 (Modi & Quittner, 2003). The CFQ-R Adolescent and Adult Self-
Report includes all 8 of the aforementioned scales and four additional scales: roles, 
vitality, health perceptions, and weight. Internal consistency for the CFQ-R Adolescent 
and Adult version ranges from .67 to .94 (Quittner et al., 2005).  
Participants were asked to rate statements on 4-point Likert scales, resulting in 
scaled scores that range from 0 to 100. Higher scores on the CFQ-R represented greater 
HRQOL.  
Given that parent-proxy report of HRQOL on the CFQ-R was only available for 
individuals under the age of 14, all parent-proxy analyses with this measure will only be 
run for participants falling under this age cutoff. 
 Pediatric Quality of Life Inventory™ Version 4.0 Short Form Generic Core Scales 
(PedsQL™ 4.0 SF15; Chan, Mangione-Smith, Burwinkle, Rosen & Varni, 2005). The 
PedQLTM Short Form (SF15) Generic Core Scale is a shortened version of the original 
PedsQL 4.0 Generic Core Scales. The following forms of the SF15 were utilized: child 
self-report and parent-proxy report for young children (ages 5-7), children (ages 8-12), 
and adolescents (ages 13-18).  
The SF15 has two subscales: physical functioning and psychosocial functioning. 
In addition, the Total Score is the sum of all questions and represents overall HRQOL. 
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Participants rated items on a 5-point scale. Items were reversed scored and linearly 
transformed to a 0-100 scale with greater scores representing greater HRQOL.  
Family Functioning 
 Family Assessment Device (FAD; Miller, Kabacoff, & Epstein, 1994) The FAD 
is a well-established measure of family functioning according to the American 
Psychological Association (Alderfer, 2008) and is based on the McMaster Model of 
Marital and Family Functioning. The measure is intended to be completed by multiple 
family members in a self-report format for children ages 12 years and above and can be 
used in an interview format for children as young as 7 years of age. The 60-item measure 
consists of 6 subscales: problem solving, communication, roles, affective 
responsiveness, affective involvement, and behavioral control. A general functioning 
dimension was derived from specific items. Participants were asked to rate statements on 
a 4-point Likert scale from 1 (strongly agree) to 4 (strongly disagree). Higher scores 
indicated “unhealthy” levels of family functioning. Scores of 2 or higher on any 
subscale, including the general functioning dimension, are considered “unhealthy,” 
(Miller, Epstein, & Bishop, 1985).  
Treatment Burden  
 Two measures were utilized to quantify child-reported treatment burden. First, as 
a part of a larger study participants completed a time use interview to identify all 
activities that were completed within the last 24-hours. The interview focused on 
identifying treatment-related activities, when they occurred, and who they occurred with. 
During the interview, participants were asked to rate each treatment activity on how 
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much it intruded on their daily life, which primed them to consider how their treatments 
impact their daily routines. Upon completion, participants rated the extent to which the 
need to complete all treatments imposes on their daily routine on a scale from 0 (not 
burdensome) to 5 (extremely burdensome). This overall question was utilized as one 
measure of the child-reported treatment-burden. 
 CFQ-R Treatment Burden Subscale. The treatment burden subscale of the CFQ-
R consists of the following 3 items: To what extent do your treatments make your daily 
life more difficult? How much time do you currently spend each day on your treatments? 
How difficult is it for you to do your treatments each day? The subscale was 
standardized and scored on a 0-100 point scale with lower levels indicating higher 
treatment burden. This method has been used in previous studies as an independent 
measure of treatment burden for CF (e.g. Sawicki, Sellers, & Robinson, 2009). This was 
the only measure of treatment burden for parent-report analyses.  
Demographic Information 
Information pertaining to the patient’s demographics include age, gender, and 
ethnicity were obtained on the CFQ-R information cover page. Additionally, information 
regarding CF severity was acquired through medical records reviews. FEV1 % during the 
appointment of study participations and past year hospitalizations were included in 
analyses to represent disease severity.  
Procedure 
 Measures for the current study were administered as part of a larger more 
extensive study.  After consenting, participants were informed that administration of the 
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study procedures would take place between provider visits, to alert them that there may 
be disruptions in the completion of some measures. Administration of the time-use 
interview and self-report questionnaires was counterbalanced. Further, administration of 
the questionnaires was done at random to eliminate effects of fatigue. Participants were 
read the instructions for each questionnaire by the researcher and asked to complete 
them; when age-appropriate, the researcher continued to administer the questionnaires in 
an interview-format. Upon completion of the study, parents were provided a copy of the 
consent form, HIPPAA authorization, and were thanked for their participation.  
Statistical Analyses 
All analyses were conducted using Statistics Package for the Social Science 
software (SPSS for Windows Version 20.0, 2011).  
For study aims 1-4, correlation analyses were conducted to examine bivariate 
relationships between family functioning, HRQOL, and both measures of treatment 
burden for child self-report measures. Regression analyses controlling for age, FEV1 %, 
and past hospitalizations were run for significant correlations.  For these specific aims, 
total family functioning was measured by the general functioning scale on the FAD. 
HRQOL was measured using the total score on the PedsQLTM SF15.  
Similarly, bivariate correlations were used to determine the relationships between 
family functioning, HRQOL, and CFQ-R treatment burden for parent-proxy report. 
Parent-proxy report analyses also utilized general family functioning on the FAD and 
total score on the PedsQLTM SF15.  
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 To investigate study aim 5, two separate models, one for self-reported treatment 
burden and one for self-reported CFQ-R treatment burden, were conducted to examine 
the potential moderation between family functioning and HRQOL. Variables were 
standardized before conducting moderation analyses. Stepwise regressions were 
conducted entering covariate information on the first step (age, FEV1 %, and past 
hospitalizations), the predictor (general family functioning) and moderator (self-report 
treatment burden or CFQ-R treatment burden) were entered in the subsequent step. The 
third step included the predictor, moderator, and their interaction term.  
 To investigate study aim 6, a model was conducted to determine the potential for 
parent-reported treatment burden, measured by the CFQ-R, to moderate the relationship 
between family functioning and HRQOL. All variables were standardized before 
conducting moderation analyses. Stepwise regressions were conducted entering the 
predictor (general family functioning) and moderator (parent-report CFQ-R treatment 
burden) in the first step. The second step included the predictor, moderator, and their 
interaction term.  
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RESULTS 
 
Participant Characteristics 
 A total of 50 (mean age = 12.6 years; SD=3.1) parent-child dyads were recruited 
for the study. Three dyads completed most, but not all, of the necessary measures. For 
these three dyads completed measures were used in appropriate analyses. Demographic 
information for participants can be found in Table 1.  
It is worth noting that the majority of participants (64%) fell within a normal 
range for FEV1% which indicates a mild degree of CF severity within the current sample 
at the time of study participation.  Further, 28% of children and 18% of parents indicated 
that their family functioned in an “unhealthy” range based on previously established 
cutoff scores (Miller et al., 1994). Means for the child-report and parent-report on the 
PedsQLTM were within an expected range for children with chronic health conditions.  
Internal Consistency 
 For the current study, internal consistency for the Family Assessment Device, 
PedsQLTM, and CFQ-R were measured using Cronbach’s alpha. Reliability coefficients 
and mean response scores for the measures by form can be found in Table 2, Table 3, 
and Table 4, respectively.  
The Family Assessment Device general functioning subscale demonstrated good 
reliability for self (α = 0.80) and parent-proxy report (α = 0.80). Some self-report 
subscales demonstrated poor to marginal reliability including roles (α = 0.35), behavioral 
control (α = 0.46), and problem solving (α = 0.59). Similarly, marginal reliability was 
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seen on a number of parent-proxy report subscales including problem solving (0.49), 
communication (0.60), affective responsiveness (0.52), affective involvement (0.56), and 
behavioral control (0.54).   The PedsQLTM SF15 demonstrated favorable reliability in 
both child self-report (0.74-0.83) and parent-report (0.87-0.89).  
Reliability for the CFQ-R varied across form. On the adolescent/adult report 
there was low reliability on the eating (α = 0.21), social (α = 0.44), treatment burden (α = 
0.16), and respiratory (α = -0.09) subscales and marginal reliability on vitality (α = 0.59), 
body image (α = 0.56) and digestion (α = 0.61) subscales. The majority of parent-report 
scales demonstrated good reliability, with marginal reliability on vitality (α = 0.59), 
school (α = 0.42), eating (α = 0.59). The majority of child-report subscales demonstrated 
good reliability, with marginal reliability seen only on the social subscale (α = 0.52).  
Self-Report Relationships 
 Correlation analyses were conducted on self-report measures to examine 
bivariate relationships between age, gender, FEV1 %, number of past hospitalizations, 
family functioning, total HRQOL on the PedsQLTM SF15 , and the potential moderators 
(self-reported treatment burden and CFQ-R treatment burden). Means, standard 
deviations, and correlations can be found in Table 5. Regarding demographic variables, 
age was significantly negatively correlated with FEV1% and positively correlated with 
past hospitalizations, indicating greater disease severity was associated with older age. 
Age was also significantly negatively correlated with family functioning and treatment 
burden, such that older patients reported greater treatment burden but better family 
functioning. Past hospitalizations was significantly negatively correlated to the 
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PedsQLTM SF15, such that greater number of hospitalizations was associated with poor 
HRQOL.  
 A series of one-way ANOVAs were conducted to determine whether self-report 
measures differed by gender. Gender was not associated with family functioning, F 
(1,48) = 0.56, p = 0.46, treatment burden, F (1,46) = 0.23, p = 0.63, or the PedsQLTM 
SF15, F (1,48) = 0.27, p = 0.61. Thus, gender was not included in any subsequent 
regression analyses.  
There was a significant negative correlation between family functioning and 
HRQOL such that “unhealthy” family functioning was associated with poor HRQOL. 
Both measures of treatment burden were also significantly correlated to HRQOL, such 
that greater treatment burden was associated with poor HRQOL. Treatment burden and 
family functioning were correlated, such that those who perceived greater treatment 
burden reported “unhealthy” family functioning. 
Multiple regression analyses were run to determine whether family functioning 
and treatment burden predicted HRQOL while controlling for age, FEV1 %, and past 
hospitalizations. In the first regression, age, FEV1 %, past hospitalizations, and general 
family functioning significantly predicted HRQOL (F(4,43)=3.83, p = 0.01, R2 = 0.26, 
R2adjusted = 0.20). Family functioning accounted for a significant amount of variance in 
HRQOL while controlling for other variables (β=-0.33, t(43)=-2.39, p = 0.02). In the 
second regression, age, FEV1 %, past hospitalizations, and self-reported treatment 
burden significantly predicted HRQOL (F(4,43)=4.14, p = 0.01, R2 = 0.28, R2adjusted = 
0.21). Self-reported treatment burden accounted for significant variance in HRQOL 
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while controlling for other variables (β=-0.35, t(43)=-2.60, p = 0.01). In the third 
regression, age FEV1 %, past hospitalizations, and CFQ-R treatment burden significantly 
predicted HRQOL (F(4,41)=3.20, p = 0.02, R2 = 0.24, R2adjusted = 0.16). CFQ-R 
treatment burden accounted for a significant amount of variance in HRQOL while 
controlling for other variables (β=0.31, t(41)=2.04, p = 0.05).  
Parent-Proxy Report Relationships 
 For parent-proxy report, bivariate correlations were conducted for family 
functioning, HRQOL on the PedsQLTM  SF15, and the moderator (CFQ-R treatment 
burden). Means, standard deviations, and correlation coefficients can be found in Table 
6. There was a significant negative correlation between family functioning and HRQOL 
such that unhealthy family functioning was associated with poor HRQOL. There was 
also a significant correlation between CFQ-R treatment burden and HRQOL, such that 
greater treatment burden was associated with poor HRQOL.  Gender of the parent was 
not significantly related to any of the measures. 
Moderation Analyses 
Based on the correlation results, three separate moderation analyses were run 
(two for self-report, one for parent-report).  
The following results pertain to self-report models. Two separate models, one for 
self-reported treatment burden and one for CFQ-R treatment burden, were run to 
examine the relationships among family functioning and HRQOL on the PedsQLTM 
SF15. Covariates including age of the child, FEV1%, and number of past 
hospitalizations for CF were included in the model. Results from the hierarchical 
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regressions can be seen in Table 5. Collinearity statistics for all variables were within 
acceptable ranges for model 1 (VIF:1.05-1.20; tolerance 0.83-0.94) and model 2 (VIF: 
1.14-1.67; tolerance 0.60-0.88).  
 In step 1, age, current FEV1%, and past hospitalizations significantly predicted 
HRQOL, R2 = 0.165, F(3,44) = 2.88, p=0.046. There was a significant main effect for 
past hospitalizations and there was a favorable statistical trend for FEV1%. In step 2, 
family functioning and the moderator, self-reported treatment burden, were added to the 
model. The addition of these two variables predicted incremental variance in HRQOL, 
∆R2 = 0.16, ∆F = 4.96, p = 0.01. The main effect for past hospitalizations remained 
significant within step 2, but no other predictors reached statistical significance. The 
addition of the interaction term in step 3 did not add incrementally to the predictive 
value of the model, ∆R2 = 0.03, ∆F =1.68, p = 0.20, indicating no moderating 
relationship.  
 Similar procedures were followed for the second self-report model. In step 1, 
age, current FEV1%, and past hospitalizations did not reach statistical significance in 
predicting HRQOL, R2 = 0.16, F(3,42) = 2.679, p = 0.059, though there was a significant 
main effect for past hospitalizations in this model. In step 2, family functioning and the 
moderator, CFQ-R treatment burden, were added to the model. The addition of these two 
variables predicted incremental variance in HRQOL, ∆R2 = 0.182, ∆F = 4.786, p = 0.01. 
The addition of the interaction term in step 3 did not add incrementally to the predictive 
value of the model, ∆R2 = 0.02, ∆F = 1.38, p = 0.25, indicating no moderating 
relationship.  
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Similar procedures were followed for the parent-proxy report CFQ-R treatment 
burden model. Collinearity statistics were within an acceptable range for all variables in 
model (VIF: 1.00-1.33; Tolerance: .76-1.00) In step 1, general family functioning and 
CFQ-R treatment burden accounted for significant variance in predicting HRQOL, R2 = 
0.0.25, F(2,23) = 3.90, p = 0.035. There was a main effect for CFQ-R treatment burden 
in the model. In step 2, the addition of the interaction term did not add incrementally to 
the predictive value of the model, ∆R2 = 0.03, ∆F = 0.86, p = 0.37, indicating no 
moderating relationship.  
Exploratory Correlations 
 Bivariate correlation analyses were conducted for self-report FAD subscales and 
the PedsQLTM SF15 and CFQ-R subscales; correlation coefficients can be found in Table 
9 and Table 10 respectively. There were no significant relationships between FAD 
subscales and either the physical subscale or psychosocial subscale on the PedsQLTM 
SF15. CFQ-R Body Image was significantly negatively correlated to affective 
responsiveness, affective involvement, and behavioral control subscales of the FAD. 
These correlations suggest that patients who reported difficulties with body image 
reported unhealthy levels of affective responsiveness, affective involvement, and 
behavioral control. 
  For parent-proxy report similar correlation analyses were conducted. PedsQLTM 
SF15 correlations can be found in Table 11. The psychosocial subscale of the PedsQLTM 
SF15 was significantly negatively correlated with the roles subscale, suggesting that 
those parents who reported more difficulty with role establishment also reported poor 
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HRQOL for their children. As seen in Table 12, several CFQ-R subscales were related to 
various FAD subscales. First, the CFQ-R physical subscale was significantly positively 
correlated to the FAD affective involvement subscale such that parents who reported 
poor physical HRQOL reported healthy functioning in the affective involvement 
domain. Both the CFQ-R eating and body image subscales were significantly positively 
correlated to the FAD communication scale such that poor communication was 
associated with better body image and eating behaviors on the CFQ-R. The CFQ-R 
respiratory symptoms subscale was significantly negatively correlated with the FAD 
problem solving subscale such that parents who reported more difficulty with problem-
solving reported that their children had more respiratory symptoms on the CFQ-R. The 
CFQ-R digestive symptoms subscale was significantly negatively correlated with FAD 
roles such that parents who reported more problems with role establishment reported that 
their children had more digestive symptoms. The CFQ-R school subscale was 
significantly positively associated with FAD problem solving and negatively associated 
with roles. This suggests that poor problem-solving was associated with better school 
HRQOL, while difficulty establishing roles is associated with poor school HRQOL.  
 Treatment burden correlations with the PedsQLTM SF15 subscales were also 
conducted. For child self-report, self-reported treatment burden was significantly 
correlated with the psychosocial subscale (r= -0.43, p = 0.002). The self-report CFQ-R 
treatment burden subscale was also significantly correlated to the psychosocial subscale 
(r = 0.32, p = 0.03). For parent-proxy report, treatment burden was significantly 
associated with the physical subscale (r = 0.45, p = 0.02).  
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CONCLUSIONS 
 
Although HRQOL has received considerable attention as the standard procedure 
for measuring general well-being in pediatric chronic illnesses, few studies have 
examined what factors influence this construct in children and adolescents with cystic 
fibrosis. Previous research in adults suggests that the complex, intensive treatment 
regimens that individuals with CF must engage in daily to prolong negative medical 
complications may at some point be too burdensome and result in lower HRQOL 
(Sawicki, Sellers, & Robinson, 2009). Further, previous research in pediatric populations 
suggests that the substantial role that families play in treatment management may alter 
traditional dynamics of the family, and subsequently impact the well-being of the child 
with the medical condition (Herzer et al., 2010; Szyndler, Towns, Asperen, & McKay, 
2005; Quittner et al., 2000; Drotar, 1997). Although these variables have been linked 
theoretically, this is the first study that seeks to understand the complex relationship 
between family functioning, treatment burden, and HRQOL in pediatric CF patients. 
Sample Characteristics 
 In general, the sample in the current study responded in ways that are consistent 
with previous studies on pediatric CF, with the exception of a lower mean FEV1 % (e.g. 
Quittner et al., 2005). This indicates that the current sample had a lower disease severity 
at the time of participation than samples in some other studies. The prevalence of 
unhealthy family functioning in both child and parent report in the current sample is 
consistent with prevalence rates from previous studies (e.g. Herzer, 2010). Mean 
HRQOL scores on both the child and parent report PedsQLTM SF15 were similar to 
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means for chronically ill children reported in previous studies (Varni, Limbers, & 
Burwinkle, 2007). Means for the treatment burden subscale on the CFQ-R were similar 
to reports for both child-report and parent-report in previous studies (Quittner et al., 
2012). Thus, it is likely that the sample is representative of the larger pediatric CF 
population and improves the generalizability of the study’s findings.  
Family Functioning and HRQOL 
It was hypothesized that family functioning would be related to HRQOL in both 
child self and parent-proxy reports. Specifically, it was hypothesized that when children 
or parents perceived there to be difficulties in family functioning, they would also 
perceive themselves or their child to experience diminished HRQOL. Results confirmed 
these hypotheses; both children and parents who reported difficulties in general 
functioning on the Family Assessment Device reported lower HRQOL scores on the 
PedsQLTM SF15 total score. Further, the relationship transcended the impact of age and 
disease severity on HRQOL, as measured by FEV1 % and past hospitalizations.   
The findings corroborate other studies that suggest family functioning is a 
prominent factor in predicting the well-being of children and adolescents with CF 
(Szyndler, Towns, Asperen, & McKay, 2005; Cappelli et al., 1988). Given that the 
family plays an influential role in management of the child’s medical care, it is likely 
that when a child feels closeness and support from their family network they thrive in 
both their medical and psychological health.  The findings also suggest that while in 
general, children and parents perceive their families to function within a healthy range, 
there is a subset who feels they experience “unhealthy” interactions within their families, 
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approximately 28% and 14% respectively in the current sample. Thus, although previous 
studies have suggested that families with CF are generally not negatively impacted by 
the disease it is important to consider the subset who are. Children from these families 
appear to be impacted substantially by the disruption within their familial interactions 
and could benefit from interventions to create familial support and increase healthy 
interactions amongst family members, ultimately promoting improved HRQOL.   
Treatment Burden and HRQOL 
 It was hypothesized that treatment burden would be related to HRQOL in both 
child self and parent-proxy reports. Specifically, it was hypothesized that when children 
or parents perceived there to be greater burden associated with their own or their child’s 
CF treatment, they would perceive themselves or their child to experience diminished 
HRQOL. In self-report this hypothesis was confirmed using two measures- the CFQ-R 
treatment burden subscale and a self-report overall treatment burden score. Both were 
significantly related to HRQOL scores after controlling for age, FEV1 %, and past 
hospitalizations. This finding contradicts findings from a previous study that found a 
non-significant relationship between self-reported treatment burden and HRQOL in 
children with CF (Ziaian et al., 2006). However, results from the current study are 
consistent with findings in adult populations (Sawicki, Sellers, & Robinson, 2009) and 
build upon findings in other pediatric populations that suggest poor familial adjustment 
is linked to greater daily stress (Thompson et al., 1992). Findings from the current study 
are the first to confirm that the perceptions of how time-consuming treatment is, how 
difficult the treatment regimen is to complete, and how much treatment interferes with 
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daily functioning directly relates to the general well-being of the child or adolescent with 
CF.  
Findings from parent-proxy report also confirmed hypotheses that parents who 
perceived their child’s CF treatment to be burdensome also perceived their children to 
have poor HRQOL.  This is the first study to investigate treatment burden perceptions in 
parents of children with CF. Consistent with previous literature in HRQOL, findings 
from the current study suggest that parents may be accurate and meaningful reporters of 
their child’s CF treatment burden although they are likely to report slightly lower 
treatment burden than children themselves.  
 The strength of the relationship between treatment burden and HRQOL across 
respondents suggests a need for increased attention in both research and clinical practice 
on measuring and monitoring treatment burden. The current study used the only known, 
available method for measuring treatment burden in CF - the CFQ-R treatment burden 
subscale. The study also sought to develop another means of measuring treatment burden 
in self-report using a time-recall interview to make treatment-related activities salient 
before participants rated their overall treatment burden. Although both of these methods 
were effective in the current study, it is likely that future research could benefit from 
more comprehensive, standardized measures of treatment burden in CF.  
Although parents appear to be reliable reporters of their child’s treatment burden, 
it is likely that their ratings are slightly skewed by their own treatment burden 
perceptions. Parents, particularly of younger children, spend a significant amount of time 
acquiring, maintaining organization, preparing, and cleaning their child’s CF treatment 
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supplies which detracts from time spent on other activities.  Currently, there is no 
measure that captures parents’ own perceptions of the impact their child’s CF treatment 
has on their own daily lives. However, based on previous research it is possible that if 
parents are negatively adjusted to the chronic disease they are more likely to impact their 
family and child in negative ways (Kulczycki, Robinson, & Berg, 1969; Patterson, 
1990). Thus, it is important that future research develops appropriate measures to 
explore the role of parents’ perception of their own treatment burden and the HRQOL of 
their child.  
 Findings from the current study also suggest that treatment burden is an 
important consideration for physicians and treatment teams in pediatric CF. It is likely 
that there is a point at which more prescribed medical treatments cause a decline in the 
general well-being of the child with CF. However, given that treatment burden is entirely 
subjective and unique to each individual patient, monitoring this would require 
consistent administration of self-report measures, particularly when medication regimens 
are increased in time or difficulty. Managing treatment burden would likely require more 
consistent conversation between patients and treatment teams in order to balance the 
medical needs of the child with their general well-being. 
Moderation Models 
 It was hypothesized that children and parents who perceived greater treatment 
burden would also perceive more “unhealthy” functioning within their family, and as a 
result, the child would experience lower HRQOL. However, results from the current 
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study suggest that the relationship between family functioning and HRQOL is not 
dependent upon treatment burden perceptions.  
Findings from the moderation analyses do shed light on several models that may 
help predict HRQOL in children with CF. In both parent-proxy and child self-report 
models, age, disease severity, family functioning, and treatment burden accounted for a 
significant portion of variance in HRQOL scores. This model highlights patient 
characteristics that may help identify children with CF who are at risk for poor HRQOL. 
Older children with CF that demonstrate greater disease severity, poor family 
functioning, and greater treatment burden should be monitored and targeted for 
prevention and interventions efforts.  
Exploratory Relationships 
 Conclusions drawn from exploratory hypotheses are limited given there was not 
sufficient statistical power to run the analyses. However, it is worth noting that unlike 
the total scores used in the main analyses, there were no consistent trends in the 
correlations of family functioning subscales and HRQOL subscales on either the 
PedsQLTM SF15 or the CFQ-R. There is a need to further examine these relationships in 
future studies to determine if there are significant trends in the areas of family 
functioning that impact the well-being of the child. Treatment burden analyses revealed 
consistent correlations with psychosocial HRQOL on the PedsQLTM SF15. This finding 
may suggest that individuals who perceive their treatment to be difficult, time-
consuming, and potentially interfering with other life domains are more likely to have 
psychological and social problems. Future studies should explore the psychological 
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impact of treatment burden on both children with CF and their parents, perhaps 
specifically within the domains of depression and anxiety.  
Limitations 
Although the current study is the first to examine relationships between family 
functioning, treatment burden and HRQOL in pediatric CF populations, there are a 
number of limitations that must be considered. First, the sample size of the study is 
relatively small and homogenous, with the majority of participants being of Caucasian 
descent. For this reason, the results of the current study may not generalize to all 
children with CF. Further, the sample is comprised of patients who regularly attend 
clinic visits with moderately healthy FEV1 % at the time of participation and thus, may 
not be representative of individuals who do not receive appropriate medical care which 
may cause diminished clinical outcomes and lower HRQOL ratings.  
Results from reliability analyses suggest that many of the subscales demonstrated 
poor to marginal reliability. There are some previous studies that have reported similar, 
marginal reliability on certain CFQ-R subscales, particularly the treatment burden 
subscale (Quittner, Sawicki, McMullen, Rasouliyan, Pasta, & Yegin, 2012). Thus, 
although this is consistent across studies, it demonstrates the need for continued 
development of measurement models for treatment burden in both children with CF and 
their parents. The poor reliability may also be a result of study procedures. Participants 
were recruited during their regularly scheduled clinic visits which tend to be lengthy in 
duration without research participation. As such, participants may have been completing 
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study questionnaires in-between provider visits or hurriedly at the conclusion of their 
appointments.  
As a result of the small sample size and limited power, more complex statistical 
analyses could not be performed. Although the models tested in the current study 
accounted for a significant portion of HRQOL, there are other factors that likely 
contribute to HRQOL ratings.  
Future Directions 
 There are a number of future research questions that need to be explored based 
on findings from the current study. First, it is important to replicate findings between 
treatment burden and HRQOL. While the current study found a significant relationship 
between the two constructs, future studies should utilize more diverse samples and those 
with greater disease severity to confirm the generalizability of the relationship. It is also 
important to continue investigating factors that contribute to HRQOL in children with 
CF. While the current study makes a significant improvement on development of a 
model to predict the general well-being of children with CF, however, exploration of 
additional factors is needed. These factors may including family SES, education level, 
peer relationships, and other contributing medical factors. 
Future research should also focus on improving measurement of treatment 
burden for both self and parent-proxy report. A comprehensive, validated instrument 
could be useful in both research and clinical settings given the importance of treatment 
burden to children with CF. The current lack of comprehensive measures for treatment 
burden limits the ability to fully explore the construct and the impact it has on families 
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and children with CF. It is also important to begin exploring parents’ own treatment 
burden perceptions. Given the role of parents in the management of their child’s CF, 
understanding parents’ own perceptions of treatment may provide insight into child 
adherence and medical outcomes.  
Summary 
 The current study found that family functioning and treatment burden are related 
to HRQOL in pediatric CF. These relationships are consistent across child self-report 
and parent-proxy report beyond age and disease severity. The study findings confirm 
that there are a subset of families who function in the “unhealthy” range, which 
negatively impacts the HRQOL of the child with CF. These families could benefit from 
clinical interventions that promote more supportive interactions between family 
members and improve the general well-being in the child with CF. Further, the study is 
the first to suggest that treatment burden perceptions are an important predictor in the 
HRQOL of children with CF, emphasizing the need for improved measurement 
instruments for use in clinical settings. More globally, the study suggests that knowledge 
of the child’s age, disease severity, family functioning, and treatment burden can assist 
in predicting the child’s HRQOL and can inform prevention and intervention efforts to 
maintain physical and psychological well-being in children with CF. 
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APPENDIX 
 
 Table 1. 
Descriptive Statistics of Child and Parent Participants  
  
 N % 
Child   
   Gender    
      Male 30 60 % 
      Female 20 40 % 
   Race/Ethnicity   
      Caucasian 45 90 % 
      African American 2 4 % 
      Hispanic 3 6 % 
  FEV1 Score at Participation   
      Normal (>80%) 32 64 % 
      Mild (60-80%) 8 16 % 
      Moderate (35-60%) 9 18 % 
      Severe (<35%) 1 2%  
 Mean SD 
Age 12.6 3.1 
Past Hospitalizations  1.03 1.30 
 N % 
Parent   
  Reporting Parent   
     Mother     42 84% 
     Father 5 10% 
     Other  3 6% 
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Table 2.  
Descriptive Statistics and Reliability for the FAD 
 
 
 
 
  
 No. of 
Items 
Mean SD Cronbach’s 
Alpha 
FAD Self-Report     
   Problem Solving  6 1.96 0.43 0.59 
   Communication 9 2.41 0.29 0.62 
   Roles 11 2.60 0.53 0.35 
   Affective Responsiveness 6 2.73  0.64 
   Affective Involvement 7 2.91 0.60 0.76 
   Behavioral Control 9 2.57 0.34 0.46 
   General Functioning 12 2.33 0.26 0.80 
FAD Parent-Report     
   Problem Solving  6 1.87 0.30 0.49 
   Communication 9 1.94 0.33 0.60 
   Roles 11 2.26 0.35 0.68 
   Affective Responsiveness 6 1.74 0.35 0.52 
   Affective Involvement 7 1.92 0.35 0.56 
   Behavioral Control 9 1.63 0.29 0.54 
   General Functioning 12 1.68 0.31 0.70 
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Table 3.  
Descriptive Statistics and Reliability for the PedsQLTM  
 
 
 
 
 
 
  
 No. of 
Items 
Mean SD Cronbach’s 
Alpha 
PedsQLTM Self-Report     
    Physical 5 74.20 19.32 0.74 
    Psychosocial 10 74.89 16.40 0.84 
    Total 15 74.67 14.30 0.83 
PedsQLTM Parent-Report     
   Physical 5 70.83 23.93 0.87 
   Psychosocial  10 66.82 18.73 0.87 
   Total 15 68.47 17.84 0.89 
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Table 4.  
Descriptive Statistics and Reliability for the CFQ-R 
 
 
 
 
  
 No. of 
 Items 
Mean SD Cronbach’s 
Alpha 
CFQR-Adolescent     
   Physical  8 24.67 6.16 0.93 
   Roles 4 11.722 2.61 0.77 
   Vitality 4 10.421 1.95 0.59 
   Emotional 4 12.79 2.49 0.62 
   Social 6 10.89 3.29 0.44 
   Body Image 3 8.895 2.40 0.56 
   Eating 3 11.421 0.84 0.21 
   Treatment Burden 3 7.474 1.54 0.16 
   Health Perceptions 3 8.526 2.14 0.78 
   Respiratory 6 20.278 9.42 -0.09 
   Digestion 3 10.278 1.74 0.61 
CFQR-Child     
   Physical  6 19.763 3.32 0.72 
   Emotional 8 25.034 3.51 0.73 
   Social 7 20.33 3.55 0.52 
   Eating 3 10.00 2.26 0.84 
   Body Image 3 10.00 5.54 0.69 
   Treatment Burden 3 9.250 2.10 0.61 
   Respiratory 4 11.61 2.63 0.77 
CFQR-Parent/Caregiver     
   Physical 8 16.78 2.33 0.64 
   Vitality 5 15.21 2.29 0.59 
   School 4 12.74 2.12 0.42 
   Eat 2 6.27 1.71 0.59 
   Body Image 3 9.21 2.43 0.63 
   Treatment Burden 3 8.07 2.31 0.78 
   Health Perceptions 3 9.86 2.03 0.81 
   Respiratory 6 18.62 4.14 0.86 
   Digestion 3 9.07 2.05 0.72 
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Table 5.  
Combined Means, Standard Deviations, and Correlations for Self-Report Predictors, 
Dependent Variables, and Moderators  
 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-
tailed) 
 
 
 
 
Variables  1. 2. 3 4. 5. 6. 7. 
1. Age        
2. FEV1% Current -0.40*       
3. Past Hospitalizations 0.298* -0.53**      
4. Peds QL SR Total -0.18 0.04 -0.32*     
5. CFQR Treatment Burden -0.40** 0.10 -0.17 0.36*    
6. General Family Functioning -0.28* 0.24 -0.05 -0.29* -0.15*   
7. SR Treatment Burden -0.01 -0.24 -0.20 -0.31* 0.-22 0.28*  
Mean 12.6 81.54 1.02 74.83 61.94 1.71 2.87 
Standard Deviation 3.07 20.49 1.30 14.14 23.60 0.43 1.66 
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Table 6. 
Combined Means, Standard Deviations, and Correlations for Parent-Proxy Report 
Predictors, Dependent Variables, and Moderators 
 
 
 
 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-
tailed) 
 
 
Variables 1. 2. 3. 
1. PedsQL PR Total    
2. General Family Functioning -0.34*   
3. CFQR Treatment Burden   0.46* 0.03  
Mean 67.74 1.68 56.32 
Std. Deviation 18.36 0.31 25.70 
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Table 7.  
Hierarchical Regression with Self-Report Family Functioning and Treatment Burden Predicting HRQOL. 
Predictor Beta Se T(df) p 
Step 1      
   Age -0.06 0.05 -1.19 0.24 
   FEV1% current -0.01 0.01 -1.69 0.09 
   Past Hospitalizations -0.32 0.13 -2.54   0.02* 
Step 2      
   Age -0.07 0.05 -1.41 0.17 
   FEV1% current -0.01 0.01 -1.06 0.30 
   Past Hospitalizations -0.32 0.12 -2.72     0.01** 
   Self-Reported Treatment Burden -0.28 0.14 -1.96 0.06 
   General Family Functioning  -0.25 0.15 -1.70 0.09 
Step 3     
   Age -0.05 0.05 -1.07 0.30 
   FEV1% current -0.01 0.01 -0.94 0.36 
   Past Hospitalizations -0.31 0.12 -2.66   0.01* 
   Self-Reported Treatment Burden -0.29 0.14 -2.07   0.05* 
   General Family Functioning  -0.22 0.15 -1.50 0.14 
   Family Functioning x SR Treatment Burden -0.16 0.13 -1.30 0.20 
     
Step 1      
   Age -0.06 0.05 -1.13 0.26 
   FEV1% current -0.01 0.01 -1.60 0.12 
   Past Hospitalizations -0.31 0.13 -2.46   0.02* 
Step 2      
   Age -0.05 0.06 -0.85 0.40 
   FEV1% current -0.01 0.01 -1.12 0.27 
   Past Hospitalizations -0.27 0.12 -2.24   0.03* 
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Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-tailed) 
 
   CFQR Treatment Burden 0.23 0.16 1.47 0.15 
   General Family Functioning  -0.26 0.15 -1.74 0.09 
Step 3     
   Age -0.04 0.06 -0.77 0.44 
   FEV1% current -0.01 0.01 -0.78 0.44 
   Past Hospitalizations -0.26 0.12 -2.09   0.04* 
   CFQR Treatment Burden 0.23 0.15 1.45 0.15 
   General Family Functioning  -0.22 0.17 -1.28 0.21 
   Family Functioning x CFQR Treatment Burden 0.10 0.18 0.56 0.58 
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Table 8.  
Hierarchical Regression with Parent-Proxy Report of Family Functioning and 
Treatment Burden Predicting HRQOL 
 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-
tailed) 
 
 
Predictor Beta Se T(df) p 
Step 1     
   CFQR Treatment Burden 0.35 0.14 2.51  0.19* 
   General Family Functioning -0.18 0.14 -1.28 0.21 
Step 2     
   CFQR Treatment Burden 0.31 0.14 2.16  0.04* 
   General Family Functioning -0.11 0.14 -0.72 0.48 
   Family Functioning x CFQR Treatment Burden -0.15 0.16 -0.93 0.37 
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Table 9.  
Correlations Between Self-Report FAD Subscales and PedsQLTM Subscales 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-
tailed) 
Subscale 1. 2. 3. 4. 5. 6. 7. 
1. FAD problem solving        
2. FAD Communication  0.59**       
3. FAD Roles  0.32*  0.27      
4. FAD Affective     
    Responsiveness 
 0.41**  0.46**  0.12     
5. FAD Affective Involvement  0.25  0.46**  0.26  0.63**    
6. FAD Behavioral Control  0.26  0.34*  0.35*  0.40**  0.26   
7. PedsQL Physical Subscale -0.22  0.01  0.01  0.19  0.22  0.20  
8. PedsQL Psychosocial 
Subscale 
-0.10 -0.10 -0.18 -0.16 -0.17 -0.06 0.32* 
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Table 10. 
Correlations between Self-Report FAD Subscales and CFQR Subscales 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01  
level (2-tailed) 
 
  
           1.         2.           3.  4.         5.      6. 
1. FAD problem solving       
2. FAD Communication       
3. FAD Roles       
4. FAD Affective  
    Responsiveness 
      
5. FAD Affective  
    Involvement 
      
6. FAD Behavioral  
    Control 
      
7. CFQR Physical  -0.10 -0.15 -0.11 0.02 0.20 0.02 
8. CFQR Role 0.19 0.34 0.01 -0.17 -0.18 0.14 
9. CFQR Vitality 0.15 0.04 -0.08 0.17 0.04 0.30 
10. CFQR Emotion 0.04 -0.10 -0.20 -0.13 -0.14 -0.06 
11. CFQR Social 0.03 0.01 -0.12 -0.15 0.09 -0.13 
12. CFQR Body Image -0.07 -0.11 -0.04 -0.45** -0.49** -0.29* 
13. CFQR Eating  -0.11 -0.19 -0.26 0.04 -0.05 -0.07 
14. CFQR Treatment Burden 0.05 0.06 -0.04 -0.08 -0.13 -0.17 
15. CFQR Health  0.12 0.06 -0.09 -0.21 -0.17 -0.25 
16. CFQR Weight -0.03 -0.16 -0.26 -0.01 -0.04 -0.36 
17. CFQR Respiratory  0.27 0.24 -0.10 0.08 0.32* 0.13 
18. CFQR Digestive  -0.23 -0.29 -0.10 -0.20 -0.19 -0.13 
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Table 11.  
Correlations between Parent-Proxy Report FAD Subscales and PedsQLTM Subscales 
Subscale 1. 2. 3. 4. 5. 6. 7. 
1. FAD Problem Solving        
2. FAD Communication 0.46**       
3. FAD Roles -0.27 -0.02      
4. FAD Affective  
    Responsiveness 
0.40** 0.52** 0.01     
5. FAD Affective  
    Involvement 
0.33* 0.44* 0.20 0.46**    
6. FAD Behavioral  
    Control 
0.18 0.32* 0.13 0.13 0.26   
7. PedsQL Physical  0.01 -0.11 -0.28 0.19 -0.11 -0.60  
8. PedsQL Psychosocial  0.01 -0.08 -0.44** -0.09 -0.21 0.13 0.55* 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level 
(2-tailed) 
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 Table 12.  
Correlations Between Parent-Proxy Report FAD Subscales and CFQR Subscales 
Note. *Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-
tailed) 
 
 
 
 
 
 
 
 
 
 
 
 
 1. 2. 3. 4. 5. 6. 
1. FAD problem solving       
2. FAD Communication       
3. FAD Roles       
4. FAD Affective  
    Responsiveness 
      
5. FAD Affective  
    Involvement 
      
6. FAD Behavioral  
    Control 
      
7. CFQR Physical  0.63 0.10 -0.15 0.51** -0.28 -0.16 
8. CFQR Emotional 0.04 0.07 0.03 -0.05 -0.12 0.34 
9. CFQR Vitality 0.15 0.02 -0.16 0.05 -0.30 -0.04 
10. CFQR Eating 0.06  0.42* -0.21 0.29 0.11 0.18 
11. CFQR Body Image   -0.01  0.41* -0.24 0.08 -0.16 0.11 
12. CFQR Treatment Burden 0.29 0.15 -0.19 0.16 0.02 0.00 
13. CFQR Health 0.19 0.26 -0.28 0.18 -0.08 0.06 
14. CFQR Respiratory -0.46*    -0.10 0.10 -0.10 -0.35 -0.31 
15. CFQR Digestive   -0.05 0.29 -0.52** 0.13 -0.21 -0.03 
16. CFQR Weight   -0.31    -0.05 0.27 0.02 -0.26 0.15 
17. CFQR School   0.42* 0.29 -0.49* -0.04 0.02 0.27 
